The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs by Karan B. Thakkar & Gauri Billa
OPINION ARTICLE
published: 12         September 2013
doi: 10.3389/fphar.2013.00113
The concept of: Generic drugs and patented drugs vs.
brand name drugs and non-proprietary (generic) name
drugs
Karan B. Thakkar1* and Gauri Billa2
1 Department of Pharmacology, Grant Government Medical College and Sir J J Group of Hospitals, Mumbai, India
2 Department of Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai, India
*Correspondence: karan_thkkr@hotmail.com
Edited by:
Wil Toenders, ToendersdeGroot BV, Netherlands
Reviewed by:
J. M. Ad Sitsen, ClinPharMed, Netherlands
Keywords: generic drugs, international non-proprietary name, pharmacoeconomics, generic name, drug costs, bioequivalence studies
Time and again the importance of generic
prescribing has been emphasized, primar-
ily to reduce the cost of drugs (Mukherjee,
2013). There are two concepts to be under-
stood here, one is generic vs. patented
drugs and the other is a drug’s “brand
name” vs. “non-proprietary name” or
“generic name.” Although, our article pri-
marily describes the Indian scenario, it can
be extrapolated to other countries also.
Non-proprietary name is the
name for the active ingredient in
the medicine that is decided by an
expert committee and is understood
internationally (WHO, 2013a). Thus,
paracetamol/acetaminophen is the non-
proprietary name (generic name) while
Crocin/Metacin/Meftal/Tylenol etc. are
brand names.
It is a well-known fact that generic
drugs are “drugs that are usually intended
to be interchangeable with an innovator
product that is manufactured without a
license from the innovator company and
marketed after the expiry date of the patent
or other exclusive rights” (WHO, 2013b).
Bioequivalence is a sine qua non to generic
drugs. Good quality bioequivalence stud-
ies will help to ensure safety, efficacy,
and potency of a generic drug. When
it is said that doctors should prescribe
generic drugs, it means that they should
prescribe drugs manufactured by other
companies after expiry of patent of par-
ent drug of the innovator company. Very
often, generic prescribing is misconceived
as prescribing by a drug’s generic name or
non-proprietary name. All generic drugs
have a brand name as well as a non-
proprietary name but all drugs having
a non-proprietary name (generic name)
may not be generic drugs.
The patent for paracetamol expired in
2007 after which numerous generic ver-
sions have been developed and sold under
various “brand names.” If one were to pre-
scribe it only by the name “paracetamol”
(generic name), it is up to the pharma-
cist to select and dispense a particular
brand, which may either be the costli-
est brand at 3.64 (0.06 $) per 500mg
tablet or it could be the cheapest brand
at 0.22 (0.004 $) per 500mg tablet or
somewhere in between (MedGuide India,
2013). A simpler and better alternative for
cost reduction would be to prescribe the
cheapest “brand” of paracetamol.
This may not be applicable in govern-
ment drug stores where usually only a
single brand of a particular drug is avail-
able. In this case, prescribing by generic
names is justified because if brand names
are used and that particular brand is not
available in the drug store, the pharmacist
will have to refer drug indexes like CIMS
etc. (CIMS—Current Index of Medical
Specialties) to find out the ingredient and
then dispense from the available stock.
This will lead to waste of time and may
also lead to errors in case the wrong drug
ingredient is dispensed (Cameron et al.,
2012). In other countries like the United
States of America or the United Kingdom,
community pharmacists play an impor-
tant role in dispensing medicines and
hence their cost awareness becomes cru-
cial. But in India, the concept of commu-
nity pharmacists doesn’t exist and hence
the onus for cost reduction, from the point
of view of drug selection, lies with the
doctors.
Thus, a better way to prescribe would
be to prescribe the cheapest brand of the
drug and include the generic name of the
drug in parenthesis, in case that particular
brand is not available. For this, the physi-
cians will have to have knowledge about
the cost of various brands of a particular
drug. It may sound time consuming but
in today’s internet age, such information is
just a click away (MedGuide India, 2013).
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